These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30619944)

  • 1. Resolution of ascites and hepatic encephalopathy and absence of variceal bleeding in decompensated hepatitis C virus cirrhosis patients.
    Romano J; Sims OT; Richman J; Guo Y; Matin T; Shoreibah M; Kommineni V; Venkata K; Massoud OI
    JGH Open; 2018 Dec; 2(6):317-321. PubMed ID: 30619944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.
    Krassenburg LAP; Maan R; Ramji A; Manns MP; Cornberg M; Wedemeyer H; de Knegt RJ; Hansen BE; Janssen HLA; de Man RA; Feld JJ; van der Meer AJ
    J Hepatol; 2021 May; 74(5):1053-1063. PubMed ID: 33242501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR.
    D'Ambrosio R; Degasperi E; Anolli MP; Fanetti I; Borghi M; Soffredini R; Iavarone M; Tosetti G; Perbellini R; Sangiovanni A; Sypsa V; Lampertico P
    J Hepatol; 2022 Feb; 76(2):302-310. PubMed ID: 34592366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
    Calvaruso V; Cabibbo G; Cacciola I; Petta S; Madonia S; Bellia A; Tinè F; Distefano M; Licata A; Giannitrapani L; Prestileo T; Mazzola G; Di Rosolini MA; Larocca L; Bertino G; Digiacomo A; Benanti F; Guarneri L; Averna A; Iacobello C; Magro A; Scalisi I; Cartabellotta F; Savalli F; Barbara M; Davì A; Russello M; Scifo G; Squadrito G; Cammà C; Raimondo G; Craxì A; Di Marco V;
    Gastroenterology; 2018 Aug; 155(2):411-421.e4. PubMed ID: 29655836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study.
    Pereira GH; Peixoto HR; Giusti ML; Souza ML; Victor LB; Fernandes F; Perez RM; Villela-Nogueira CA
    Braz J Infect Dis; 2022; 26(5):102697. PubMed ID: 36037847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study.
    Ji F; Wang W; Dang S; Wang S; Li B; Bai D; Zhao W; Deng H; Tian C; Li Z
    Infect Agent Cancer; 2017; 12():48. PubMed ID: 28924449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response.
    Corma-Gómez A; Macías J; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Santos M; Real LM; Palacios R; Santos IL; Geijo P; Imaz A; Merino D; Galindo MJ; Reus-Bañuls S; López-Ruz MÁ; Galera C; Pineda JA;
    AIDS; 2021 Nov; 35(13):2119-2127. PubMed ID: 34049354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
    Tada T; Kurosaki M; Nakamura S; Hasebe C; Kojima Y; Furuta K; Kobashi H; Kimura H; Ogawa C; Yagisawa H; Uchida Y; Joko K; Akahane T; Arai H; Marusawa H; Narita R; Ide Y; Sato T; Kusakabe A; Tsuji K; Mori N; Kondo M; Mitsuda A; Izumi N
    J Med Virol; 2021 Nov; 93(11):6247-6256. PubMed ID: 34170517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early liver function improvement following successful treatment of chronic hepatitis C in patients with decompensated cirrhosis: a real-life study.
    Lourenço MS; Zitelli PMY; Cunha-Silva M; Oliveira AIN; Lima RGR; Souza EO; Oliveira CP; Sevá-Pereira T; Carrilho FJ; Pessoa MG; Mazo DF
    Clinics (Sao Paulo); 2021; 76():e3186. PubMed ID: 34817045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated?
    Hanafy AS; Bassiony MA; Basha MAA
    Hepatol Int; 2019 Mar; 13(2):165-172. PubMed ID: 30758786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical outcomes and impact of SVR in American and Chinese patients with chronic hepatitis C.
    Rao H; Liu H; Wu E; Yang M; Feng B; Lin A; Fei R; Fontana RJ; Wei L; Lok AS
    JHEP Rep; 2020 Aug; 2(4):100136. PubMed ID: 32715286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis.
    Piedade J; Guimarães L; Duarte J; Gouveia L; Garfinkel T; Veiga Z; Alcântara C; Perazzo H; Fernandes F; Pereira G
    Clin Exp Hepatol; 2022 Dec; 8(4):284-292. PubMed ID: 36683870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Follow-Up of Advanced Liver Disease after Sustained Virological Response to Treatment of Hepatitis C with Direct-Acting Antivirals: Outcomes from a Real-World Portuguese Cohort.
    Pereira Guedes T; Fragoso P; Lemos C; Garrido M; Silva J; Falcão D; Maia L; Moreira T; Manuel Ferreira J; Pedroto I
    GE Port J Gastroenterol; 2020 Apr; 27(3):149-159. PubMed ID: 32509920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.
    Cheung MCM; Walker AJ; Hudson BE; Verma S; McLauchlan J; Mutimer DJ; Brown A; Gelson WTH; MacDonald DC; Agarwal K; Foster GR; Irving WL;
    J Hepatol; 2016 Oct; 65(4):741-747. PubMed ID: 27388925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.
    Corma-Gómez A; Macías J; Téllez F; Freyre-Carrillo C; Morano L; Rivero-Juárez A; Ríos MJ; Alados JC; Vera-Méndez FJ; Merchante N; Palacios R; Granados R; Merino D; De Los Santos I; Pineda JA
    Clin Infect Dis; 2020 Dec; 71(9):2354-2362. PubMed ID: 31754695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recompensation of complications in patients with hepatitis B virus-related decompensated cirrhosis treated with entecavir antiviral therapy].
    Zhang T; Deng Y; Kang HY; Xiang HL; Nan YM; Hu JH; Meng QH; Fang JL; Xu J; Wang XM; Zhao H; Pan CQ; Jia JD; Xu XY; Xie W
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jul; 31(7):692-697. PubMed ID: 37580250
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of Baveno VII criteria for recompensation in entecavir-treated patients with hepatitis B-related decompensated cirrhosis.
    Wang Q; Zhao H; Deng Y; Zheng H; Xiang H; Nan Y; Hu J; Meng Q; Xu X; Fang J; Xu J; Wang X; You H; Pan CQ; Xie W; Jia J
    J Hepatol; 2022 Dec; 77(6):1564-1572. PubMed ID: 36038017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study.
    Berkan-Kawińska A; Piekarska A; Janczewska E; Lorenc B; Tudrujek-Zdunek M; Tomasiewicz K; Berak H; Horban A; Zarębska-Michaluk D; Pabjan P; Buczyńska I; Pazgan-Simon M; Dybowska D; Halota W; Pawłowska M; Klapaczyński J; Mazur W; Czauż-Andrzejuk A; Socha Ł; Laurans Ł; Garlicki A; Sitko M; Jaroszewicz J; Citko J; Dobracka B; Krygier R; Białkowska-Warzecha J; Tronina O; Belica-Wdowik T; Baka-Ćwierz B; Flisiak R
    Liver Int; 2021 Aug; 41(8):1789-1801. PubMed ID: 33655628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-associated decompensated liver cirrhosis with refractory hepatic encephalopathy successfully treated by balloon-occluded retrograde transvenous obliteration after sofosbuvir/velpatasvir.
    Takakusagi S; Shimizu M; Yokoyama Y; Kizawa K; Marubashi K; Kosone T; Sato K; Kakizaki S; Takagi H; Uraoka T
    Clin J Gastroenterol; 2020 Dec; 13(6):1303-1309. PubMed ID: 32914297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.